Cargando…

Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015

Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is an emerging threat to TB control in Ukraine, a country with the third highest XDR TB burden globally. We used whole-genome sequencing of a convenience sample to identify bacterial genetic and patient-related factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Merker, Matthias, Nikolaevskaya, Elena, Kohl, Thomas A., Molina-Moya, Barbara, Pavlovska, Olha, Brännberg, Patrik, Dudnyk, Andrii, Stokich, Valentyna, Barilar, Ivan, Marynova, Iryna, Filipova, Tetiana, Prat, Cristina, Sjöstedt, Anders, Dominguez, Jose, Rzhepishevska, Olena, Niemann, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045844/
https://www.ncbi.nlm.nih.gov/pubmed/32091369
http://dx.doi.org/10.3201/eid2603.190525
_version_ 1783501856315539456
author Merker, Matthias
Nikolaevskaya, Elena
Kohl, Thomas A.
Molina-Moya, Barbara
Pavlovska, Olha
Brännberg, Patrik
Dudnyk, Andrii
Stokich, Valentyna
Barilar, Ivan
Marynova, Iryna
Filipova, Tetiana
Prat, Cristina
Sjöstedt, Anders
Dominguez, Jose
Rzhepishevska, Olena
Niemann, Stefan
author_facet Merker, Matthias
Nikolaevskaya, Elena
Kohl, Thomas A.
Molina-Moya, Barbara
Pavlovska, Olha
Brännberg, Patrik
Dudnyk, Andrii
Stokich, Valentyna
Barilar, Ivan
Marynova, Iryna
Filipova, Tetiana
Prat, Cristina
Sjöstedt, Anders
Dominguez, Jose
Rzhepishevska, Olena
Niemann, Stefan
author_sort Merker, Matthias
collection PubMed
description Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is an emerging threat to TB control in Ukraine, a country with the third highest XDR TB burden globally. We used whole-genome sequencing of a convenience sample to identify bacterial genetic and patient-related factors associated with MDR/XDR TB in this country. MDR/XDR TB was associated with 3 distinct Mycobacterium tuberculosis complex lineage 2 (Beijing) clades, Europe/Russia W148 outbreak, Central Asia outbreak, and Ukraine outbreak, which comprised 68.9% of all MDR/XDR TB strains from southern Ukraine. MDR/XDR TB was also associated with previous treatment for TB and urban residence. The circulation of Beijing outbreak strains harboring broad drug resistance, coupled with constraints in drug supply and limited availability of phenotypic drug susceptibility testing, needs to be considered when new TB management strategies are implemented in Ukraine.
format Online
Article
Text
id pubmed-7045844
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-70458442020-03-07 Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015 Merker, Matthias Nikolaevskaya, Elena Kohl, Thomas A. Molina-Moya, Barbara Pavlovska, Olha Brännberg, Patrik Dudnyk, Andrii Stokich, Valentyna Barilar, Ivan Marynova, Iryna Filipova, Tetiana Prat, Cristina Sjöstedt, Anders Dominguez, Jose Rzhepishevska, Olena Niemann, Stefan Emerg Infect Dis Research Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is an emerging threat to TB control in Ukraine, a country with the third highest XDR TB burden globally. We used whole-genome sequencing of a convenience sample to identify bacterial genetic and patient-related factors associated with MDR/XDR TB in this country. MDR/XDR TB was associated with 3 distinct Mycobacterium tuberculosis complex lineage 2 (Beijing) clades, Europe/Russia W148 outbreak, Central Asia outbreak, and Ukraine outbreak, which comprised 68.9% of all MDR/XDR TB strains from southern Ukraine. MDR/XDR TB was also associated with previous treatment for TB and urban residence. The circulation of Beijing outbreak strains harboring broad drug resistance, coupled with constraints in drug supply and limited availability of phenotypic drug susceptibility testing, needs to be considered when new TB management strategies are implemented in Ukraine. Centers for Disease Control and Prevention 2020-03 /pmc/articles/PMC7045844/ /pubmed/32091369 http://dx.doi.org/10.3201/eid2603.190525 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Merker, Matthias
Nikolaevskaya, Elena
Kohl, Thomas A.
Molina-Moya, Barbara
Pavlovska, Olha
Brännberg, Patrik
Dudnyk, Andrii
Stokich, Valentyna
Barilar, Ivan
Marynova, Iryna
Filipova, Tetiana
Prat, Cristina
Sjöstedt, Anders
Dominguez, Jose
Rzhepishevska, Olena
Niemann, Stefan
Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015
title Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015
title_full Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015
title_fullStr Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015
title_full_unstemmed Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015
title_short Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015
title_sort multidrug- and extensively drug-resistant mycobacterium tuberculosis beijing clades, ukraine, 2015
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045844/
https://www.ncbi.nlm.nih.gov/pubmed/32091369
http://dx.doi.org/10.3201/eid2603.190525
work_keys_str_mv AT merkermatthias multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT nikolaevskayaelena multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT kohlthomasa multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT molinamoyabarbara multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT pavlovskaolha multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT brannbergpatrik multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT dudnykandrii multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT stokichvalentyna multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT barilarivan multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT marynovairyna multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT filipovatetiana multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT pratcristina multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT sjostedtanders multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT dominguezjose multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT rzhepishevskaolena multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015
AT niemannstefan multidrugandextensivelydrugresistantmycobacteriumtuberculosisbeijingcladesukraine2015